July 2025 in “Indus journal of bioscience research.” This study found that women with polycystic ovary syndrome showed significant differences in clinical symptoms, hormone levels, and ovarian morphology compared to healthy controls, such as higher body mass index, menstrual irregularities, elevated luteinizing hormone, and polycystic ovarian morphology, suggesting these factors enhance diagnostic accuracy.
64 citations
,
May 2003 in “Journal of health psychology” This study found that women with PCOS reported higher overall psychological distress, but there was no significant link between their perceived hirsutism and this distress.
June 2026 in “Biomedical and Therapeutics Letters” This review discusses AMH and ovarian morphology as complementary markers in diagnosing PCOS/PMOS and reports no new clinical results, highlighting the need for a multidomain approach in diagnosis and treatment.
633 citations
,
September 1998 in “The Journal of Clinical Endocrinology and Metabolism” This study observed that among a cohort of reproductive-aged women in the U.S., the prevalence of PCOS was about 4.0%, with no significant racial differences between White and Black women.
September 2021 in “Physiology News” This abstract provides no research results; it includes only formatting instructions and placeholders without scientific information.
August 2025 in “International Journal For Multidisciplinary Research” This study highlights that stress and coping styles significantly influence the symptom severity of Indian women with PCOS, emphasizing a need for culturally appropriate interventions to improve quality of life.
2 citations
,
June 2009 in “The Nurse practitioner” This article highlights that many women with PCOS are unaware of their condition and its increased risks for type 2 diabetes and cardiovascular disease, and it offers no new clinical findings.
467 citations
,
October 2014 in “European Journal of Endocrinology” This paper reviews the diagnostic criteria, etiological factors, and treatment approaches for PCOS, highlighting the importance of considering metabolic issues such as insulin resistance and obesity, but reports no new findings.
2 citations
,
June 2014 in “مجلة مركز بحوث التقنيات الاحيائية” This study reported that patients with PCOS and thyroid hormone disturbances had specific TPO gene mutations and differing thyroid hormone levels compared to those without disturbances or healthy controls.
December 2023 in “Advances in Integrative Medicine” This case study suggests that using Boswellia sacra (Frankincense) both orally and topically, along with diet and lifestyle changes, may rapidly resolve pilonidal sinus disease, a condition commonly marked by high recurrence, although no prior studies have investigated this treatment for PNS.
46 citations
,
November 2004 in “Lipids” This study suggests PPAR isotypes play distinct roles in skin, influencing epidermal barrier formation, sebocyte differentiation, and lipid production, with potential implications for treating skin disorders.
June 2022 in “Plastic & Reconstructive Surgery Global Open” This document reviews various studies presented at the Plastic Surgery Research Council (PSRC) Annual Meetings and reports no new research findings; it discusses topics ranging from reconstructive techniques to gender-affirming surgeries.
October 2022 in “Aesthetic Cosmetology and Medicine” This study reviews polycystic ovary syndrome, focusing on its hormonal and metabolic disturbances and related skin lesions, but provides no new clinical findings.
This study found a higher prevalence of PCOS among young women, with significant associations to factors like diabetes, non-vegetarian diet, and family history.
This study protocol aims to explore the prevalence of polycystic ovary syndrome among female pediatric patients with spina bifida, focusing on metabolic and phenotypic differences, but reports no new results yet.
26 citations
,
February 1998 in “Chemico-Biological Interactions” This review discusses recent molecular biology advances in the human phenol sulfotransferase gene family and reports no new results; the authors highlight its relevance for studies of endogenous and xenobiotic metabolism.
April 2017 in “European Psychiatry” This study found that females treated with atypical anti-psychotics had a higher prevalence of probable polycystic ovarian syndrome compared to normal controls.
August 2020 in “International research journal of pharmacy” This study found that lifestyle interventions, along with regular medication, improved the quality of life for women with PCOS.
January 2013 in “Chinese Journal of Hospital Pharmacy” This study developed a precise and sensitive HPLC-MS/MS method for analyzing the pharmacokinetics of perospirone hydrochloride in human plasma, establishing it as suitable for clinical studies.
2 citations
,
June 2024 in “Anti-Aging Eastern Europe” This review discusses the varied clinical presentations and management challenges of Polycystic Ovary Syndrome across different life stages, reporting no new clinical findings.
This review examines the potential of Parquetina nigrescens for managing Polyendocrine Metabolic Ovarian Syndrome, emphasizing its pharmacological activities and highlighting its promise as an affordable complementary therapy.
2 citations
,
September 2025 in “Scientific Reports” This study found that women with polycystic ovary syndrome have a higher prevalence of autoimmune thyroid disease compared to those without the condition, highlighting the importance of screening for thyroid issues in this population.
96 citations
,
October 2021 in “Reproductive Sciences” Women with PCOS often experience depression and anxiety, affecting their quality of life.
1 citations
,
July 2024 in “Journal of Investigative Dermatology” TAK-279 effectively reduces psoriasis symptoms and is safe.
June 2026 in “Biomolecules and Biomedicine” This study found that women with PCOS had higher levels of serum phoenixin isoforms, which correlated with reproductive and metabolic markers, suggesting these isoforms may have a potential diagnostic role.
2 citations
,
July 2023 in “Frontiers in Endocrinology” This review identified and evaluated polycystic ovary syndrome models of care, finding that only three fully aligned with international guidelines and generally received positive feedback on satisfaction; just one showed an impact on patients' BMI.
December 2022 in “Cumhuriyet medical journal” This study observed that women with PCOS and no hyperandrogenism (group 3) had similar metabolic issues to those with classic PCOS, while those with no menstrual dysfunction (group 2) had milder issues related to lipid and insulin resistance.
7 citations
,
January 2024 in “Medicinska istrazivanja” This review outlines the complexities and varied manifestations of polycystic ovary syndrome, highlighting challenges in diagnosis and management but reports no new clinical findings.
October 2025 in “Cermin Dunia Kedokteran” This review discusses personalized treatment strategies and management approaches for chronic obstructive pulmonary disease (COPD), emphasizing the need for multi-aspect assessments, but reports no new clinical findings.
1540 citations
,
October 2008 in “Fertility and Sterility” This review discusses the definition of polycystic ovary syndrome proposed by the AE-PCOS Society Task Force, emphasizing hyperandrogenism, ovarian dysfunction, and excluding related disorders, while noting potential variations needing more research.